Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|September 30, 2024
Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigensJonas Fischer, Katherine H Shutta, Chen Chen, et al.
BMJ Oncology|April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancerSepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
Scientific Reports|May 5, 2023
Activity of pemetrexed in pre-clinical chordoma models and humansSantosh Kesari, Feng Wang, Tiffany Juarez, et al.
Molecular Cancer Research : MCR|March 11, 2018
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal CancersMohamed E Salem, Alberto Puccini, Axel Grothey, et al.
Journal of Neuro-Oncology|May 31, 2018
Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial designRichard G Everson, Yuuri Hashimoto, Jacob L Freeman, et al.
British Journal of Cancer|September 3, 2024
Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumorsSaikat Chowdhury, Joanne Xiu, Jennifer R Ribeiro, et al.
The Journal of Molecular Diagnostics : JMD|September 25, 2021
Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer TypesAndrew Elliott, Jian Zhang, Qing Zhang, et al.
JCO Precision Oncology|August 5, 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract CancersThejus Jayakrishnan, Yasmine Baca, Joanne Xiu, et al.
Cancer Gene Therapy|August 22, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancerMidhun Malla, Sachin Kumar Deshmukh, Sharon Wu, et al.
International Journal of Cancer|May 26, 2020
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumorsMohamed E Salem, J Nicholas Bodor, Alberto Puccini, et al.
Pageof 17